Advanced search
Publication Cover
International Journal of Chronic Obstructive Pulmonary Disease Volume 16, 2021 - Issue
Submit an article Journal homepage
207
Views
9
CrossRef citations to date
0
Altmetric
Original Research

A Dose-Ranging Study of the Novel Inhaled Dual PDE 3 and 4 Inhibitor Ensifentrine in Patients with COPD Receiving Maintenance Tiotropium Therapy

Gary T Ferguson1 Pulmonary Research Institute of Southeast Michigan, Farmington Hills, MI, USA
,
Edward M Kerwin2 Altitude Clinical Consulting, Medford, OR, USAORCID Iconhttps://orcid.org/0000-0002-1697-9036
ORCID Icon,
Tara Rheault3 Verona Pharma, Plc, Raleigh, NC, USACorrespondence[email protected]
,
Thomas Bengtsson4 Stat Mind AB, Lund, Sweden
&
Kathleen Rickard3 Verona Pharma, Plc, Raleigh, NC, USAORCID Iconhttps://orcid.org/0000-0002-2542-6011
ORCID Icon
Pages 1137-1148 | Published online: 22 Apr 2021

Citations (9)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (3)

James F Donohue, Tara Rheault, Margot MacDonald-Berko, Thomas Bengtsson & Kathleen Rickard. (2023) Ensifentrine as a Novel, Inhaled Treatment for Patients with COPD. International Journal of Chronic Obstructive Pulmonary Disease 18, pages 1611-1622.
Read now
Luigino Calzetta, Elena Pistocchini, Alfredo Chetta, Paola Rogliani & Mario Cazzola. (2023) Experimental drugs in clinical trials for COPD: artificial intelligence via machine learning approach to predict the successful advance from early-stage development to approval. Expert Opinion on Investigational Drugs 32:6, pages 525-536.
Read now
Clémence Martin, Pierre-Régis Burgel & Nicolas Roche. (2021) Inhaled Dual Phosphodiesterase 3/4 Inhibitors for the Treatment of Patients with COPD: A Short Review. International Journal of Chronic Obstructive Pulmonary Disease 16, pages 2363-2373.
Read now

Articles from other publishers (6)

Michael Troy, Joseph Van Vleet, Donald Tashkin & Igor Barjaktarevic. (2023) Recent advances predict a bright future for nebulizers. Current Opinion in Pulmonary Medicine 29:2, pages 123-132.
Crossref
Isabel UWAGBOE, Ian M. ADCOCK, Federica LO BELLO, Gaetano CARAMORI & Sharon MUMBY. (2022) New drugs under development for COPD. Minerva Medica 113:3.
Crossref
Marco Mergiotti, Alessandra Murabito, Giulia Prono & Alessandra Ghigo. (2022) CFTR Modulator Therapy for Rare CFTR Mutants. Journal of Respiration 2:2, pages 59-76.
Crossref
Mario Cazzola, Clive Page & Maria Gabriella Matera. (2022) Ensifentrine: A First-in-class Bifunctional Drug for the Treatment of Chronic Obstructive Pulmonary Disease. US Respiratory & Pulmonary Diseases 7:2, pages 48.
Crossref
Mario Cazzola, Josuel Ora, Luigino Calzetta, Paola Rogliani & Maria Gabriella Matera. (2022) The future of inhalation therapy in chronic obstructive pulmonary disease. Current Research in Pharmacology and Drug Discovery 3, pages 100092.
Crossref
Paul Zarogoulidis, Christoforos Kosmidis, Nikolaos Kougkas, Aimilios Lallas, Dimitris Petridis, Wolfgang Hohenforst-Schmidt, Haidong Huang, Lutz Freitag & Chrisanthi Sardeli. (2021) Modification of Apremilast from Pills to Aerosol a Future Concept. International Journal of Environmental Research and Public Health 18:21, pages 11590.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.